We are live on ! Find out more
HM Payson & Co

HM Payson & Co Portfolio holdings

AUM $7.54B Turnover 8.06%
1-Year Est. Return 31.34%
 

H.M. Payson & Co. is an investment and trust firm founded in 1854 by Henry Martyn Payson, a Portland native who started as a stock and bond broker after returning from the California gold rush. Water utilities were its early specialty: Payson first dealt in water bonds in 1866, as the Portland Water Company took shape, the firm underwrote water bond issues until 1981, and in 1926 two of its partners and five outsiders formed a water utility holding company, Consumer's Water Company, which Payson stayed connected to until 1999. For clients' money it stuck to cautious, blue-chip securities, and in the 1920s it refused to offer margin accounts even though it lost half of its brokerage business in 1928 as a result. The firm later moved trust management from commissions to a fee, and in 2000 it received a state charter to operate as a trust company.

This Fund
S&P 500
This Quarter Est. Return
+0.49%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.99%
AUM
$2.01B
AUM Growth
+$8.61M
Cap. Flow
+$7.59M
Cap. Flow %
0.38%
Top 10 Hldgs %
24.23%
Holding
304
New
7
Increased
67
Reduced
150
Closed
9
Avg Time Held
1.7 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
1.7 years

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$11.9M
2
AGCO icon
AGCO
AGCO
+$7.19M
3
ESRX
Express Scripts Holding
ESRX
+$4.02M
4
VOD icon
Vodafone
VOD
+$4.01M
5
SNY icon
Sanofi
SNY
+$3.47M

Sector Composition

Rank Sector Weight
1 Healthcare 15.66%
2 Technology 14.51%
3 Financials 12.96%
4 Industrials 11.56%
5 Miscellaneous 10.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
XOM icon
1
ExxonMobil
XOM
$682B
$79.6M 3.96%
956,417
+9,251
+1% +$795K
2013 Q2
8 quarters
AAPL icon
2
Apple
AAPL
$5.11T
$58.8M 2.93%
1,876,488
+17,656
+0.9% +$565K
2013 Q2
8 quarters
JNJ icon
3
Johnson & Johnson
JNJ
$671B
$56.4M 2.81%
579,189
-8,256
-1% -$827K
2013 Q2
8 quarters
MSFT icon
4
Microsoft
MSFT
$3.76T
$47.1M 2.34%
1,067,311
+11,308
+1% +$516K
2013 Q2
8 quarters
MCD icon
5
McDonald's
MCD
$195B
$43.5M 2.16%
457,148
-275
-0.1% -$26.6K
2013 Q2
8 quarters
RTX icon
6
RTX
RTX
$267B
$41.9M 2.08%
599,485
+9,410
+2% +$690K
2013 Q2
8 quarters
PG icon
7
Procter & Gamble
PG
$398B
$41.7M 2.08%
533,036
+5,548
+1% +$446K
2013 Q2
8 quarters
PFE icon
8
Pfizer
PFE
$162B
$41.4M 2.06%
1,301,110
+555
+0% +$18.1K
2013 Q2
8 quarters
IBM icon
9
IBM
IBM
$218B
$39M 1.94%
251,017
+10,547
+4% +$1.7M
2013 Q2
8 quarters
ABT icon
10
Abbott
ABT
$181B
$37.5M 1.87%
763,893
+5,017
+0.7% +$241K
2013 Q2
8 quarters
VEA icon
11
Vanguard FTSE Developed Markets ETF
VEA
$223B
$37.1M 1.85%
936,683
-77,210
-8% -$3.19M
2013 Q2
8 quarters
JPM icon
12
JPMorgan Chase
JPM
$876B
$37.1M 1.84%
546,955
+2,680
+0.5% +$175K
2013 Q2
8 quarters
INTC icon
13
Intel
INTC
$293B
$36.9M 1.84%
1,214,426
+12,313
+1% +$398K
2013 Q2
8 quarters
GD icon
14
General Dynamics
GD
$96.1B
$35.7M 1.78%
251,948
-1,459
-0.6% -$203K
2013 Q2
8 quarters
IGSB icon
15
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.7B
$35.2M 1.75%
668,148
+14,080
+2% +$742K
2013 Q2
8 quarters
WFC icon
16
Wells Fargo
WFC
$248B
$34.2M 1.7%
608,539
+9,234
+2% +$515K
2013 Q2
8 quarters
PEP icon
17
PepsiCo
PEP
$194B
$33.7M 1.68%
360,715
-257
-0.1% -$24.6K
2013 Q2
8 quarters
WMB icon
18
Williams Companies
WMB
$84.3B
$32.2M 1.6%
560,584
+2,353
+0.4% +$121K
2013 Q2
8 quarters
TJX icon
19
TJX Companies
TJX
$143B
$31.4M 1.56%
950,254
-10,486
-1% -$349K
2013 Q2
8 quarters
VWO icon
20
Vanguard FTSE Emerging Markets ETF
VWO
$115B
$30.6M 1.52%
748,594
-59,899
-7% -$2.57M
2013 Q2
8 quarters
DEO icon
21
Diageo
DEO
$56.1B
$28.8M 1.43%
248,294
+10,342
+4% +$1.18M
2013 Q2
8 quarters
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.25T
$28.5M 1.42%
209,527
+8,246
+4% +$1.18M
2013 Q2
8 quarters
ORCL icon
23
Oracle
ORCL
$359B
$27.6M 1.37%
684,939
+29,534
+5% +$1.28M
2013 Q2
8 quarters
GE icon
24
GE Aerospace
GE
$339B
$25.9M 1.29%
203,016
-6,248
-3% -$810K
2013 Q2
8 quarters
CVX icon
25
Chevron
CVX
$422B
$25.3M 1.26%
262,761
+15,634
+6% +$1.64M
2013 Q2
8 quarters

Similar funds

HM Payson & Co's Q2 2015 Portfolio in Review

As of Q2 2015, HM Payson & Co held 304 positions worth $2.01B, up 0.43% from $2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

HM Payson & Co's Q2 2015 filing shows 7 new, 67 increased, 150 reduced and 9 closed positions. Its largest new stake was Viatris: 142,723 shares worth $9.7M. The largest sale was Baxter International, an estimated $11.9M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • HM Payson & Co's largest Q2 2015 buy was Viatris: 142,723 shares worth $9.7M.
  • HM Payson & Co added most to Precision Castparts in Q2 2015, an estimated $14.5M increase.
  • HM Payson & Co's biggest Q2 2015 reduction was Baxter International, cutting an estimated $11.9M.
  • HM Payson & Co fully exited Kohl's in Q2 2015, selling an estimated $765K.
  • HM Payson & Co's ten largest holdings make up 24% of its $2.01B portfolio in Q2 2015.
  • HM Payson & Co opened 7 new positions and closed 9 in Q2 2015.
  • HM Payson & Co's portfolio value rose 0.43% quarter-over-quarter to $2.01B.

Based on HM Payson & Co's 13F filing for Q2 2015, filed 11 Aug 2015.